What is ImmunityBio, Inc.'s PP&E (net)?

ImmunityBio, Inc. (IBRX) reported PP&E (net) of $112.79M in Q1 2026.

How has ImmunityBio, Inc.'s PP&E (net) changed year-over-year?

ImmunityBio, Inc.'s PP&E (net) decreased by 16.6% year-over-year, from $135.27M to $112.79M.

What is the long-term trend for ImmunityBio, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), ImmunityBio, Inc.'s PP&E (net) has grown at a 9.5% compound annual growth rate (CAGR), from $72.54M to $114.26M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

ImmunityBio, Inc. IBRX PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.66B+6.2%

Johnson & JohnsonJNJ

$23.27B+11.5%

Merck & Co.MRK

$25.43B+2.6%

Gilead SciencesGILD

$5.64B+4.0%

CG OncologyCGON

$15.07M+5,610%

Immunovant, Inc.IMVT

$443K-47.5%

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s PP&E (net)?: ImmunityBio, Inc. (IBRX) reported PP&E (net) of $112.79M in Q1 2026.
How has ImmunityBio, Inc.'s PP&E (net) changed year-over-year?: ImmunityBio, Inc.'s PP&E (net) decreased by 16.6% year-over-year, from $135.27M to $112.79M.
What is the long-term trend for ImmunityBio, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), ImmunityBio, Inc.'s PP&E (net) has grown at a 9.5% compound annual growth rate (CAGR), from $72.54M to $114.26M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.